Peer-influenced content. Sources you trust. No registration required. This is HCN.
Cancer Therapy Advisor
The brothers falsely inflated OP-1250’s overall response rate from 9% to 17% and bumped up the expected phase II response rate from 18% to 36%.
Oncology Pharmacy February 2nd 2026
Epoch Health
“Patients and doctors [lack] enough research to inform medical guidelines and many patients are using these products without talking to their doctor about them.” —Senior White House official
Family Medicine/General Practice January 21st 2026
Oncology News Central (ONC)
Providers nationwide are experiencing an uptick in health plans denying payments by improperly asserting that providers are not coding their claims correctly.
Hematology/Oncology November 17th 2025
DIET & NUTRITION 
PATIENT EDUCATION 
OBESITY/WEIGHT MANAGEMENT 
EXERCISE/TRAINING 
LEGAL MATTERS 
GUIDELINES/RECOMMENDATIONS